AbbVie (ABBV) Return on Invested Capital (2013 - 2026)

AbbVie (ABBV) has reported Return on Invested Capital for 14 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital rose to 0.0% in Q1 2026 per ABBV's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q2 2023 and bottomed at 0.0% in Q2 2024.
• Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
• On a YoY basis, Return on Invested Capital climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
• AbbVie's Return on Invested Capital stood at 0.0% in 2022, then declined by 25 bps to 0.0% in 2023, then fell by 10 bps to 0.0% in 2024, then gained by 9 bps to 0.0% in 2025, then advanced by 1 bps to 0.0% in 2026.
• Business Quant data shows ABBV's Return on Invested Capital at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.